After allogenic bone marrow transplantation agent of hemorrhagic cystitis: BK virus

Berber Ilhami, Koroglu Mustafa, Erkurt Mehmet Ali, Oguz Fatih, Altintas Ramazan, Kaya Emin, Kuku Irfan, Ulutas Ozkan

Department of Hematology, Faculty of Medicine, Inonu University, Malatya, Turkey.
Department of Hematology, Faculty of Medicine, Inonu University, Malatya, Turkey;.
Department of Nephrology, Faculty of Medicine, Inonu University, Malatya, Turkey.
Department of Urology, Faculty of Medicine, Inonu University, Malatya, Turkey.

DOI: 10.4236/crcm.2013.25080                

Abstract

Hemorrhagic cystitis is a common and in its severe form potentially life threatening complication of hematopoietic stem cell transplantation. Hemorrhagic cystitis is defined as a diffuse inflammatory condition of the urinary bladder due to an infectious or noninfectious etiology resulting in bleeding from the bladder mucosa. Hemorrhagic cystitis is characterized by lower urinary tract symptoms including dysuria, hematuria and hemorrhage. The most common cause is a bacterial infection that usually responds promptly to treatment. But chronic and recurrent hemorrhagic cystitis often arises from anticancer chemotherapy or radiotherapy for the treatment of pelvic malignancies. Infectious etiologies are less common causes of chronic hemorrhagic cystitis except in immunocompromised hosts like bone marrow transplant recipients. Hemorrhagic cystitis is a significant complication of bone marrow transplantation which influences economic and survival outcome. Hemorrhagic cystitis can be divided into two classes according to onset time; early and late onset time. Earlyonset hemorrhagic cystitis is commonly associated used with chemo-radiotherapy protocols in some of the preparatory regimens. More than one factor is accused in the etiology of late onset hemorrhagic cystitis. Here, we present a patient whose hematuria started after 54 days from allogeneic stem cell transplantation.

Keywords

Allogenic Bone Marrow Transplantation

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Manikandan, R., Kumar, S. and Dorairajan, L.N. (2010) Hemorrhagic cystitis: A challenge to the urologist. Indian Journal of Urology, 26, 159-166.
[2]	Daniel, B.D., Jose, A.K. and Duncan, T.W. (2009) Pediatric hemorrhagic cystitis. Journal of Pediatric Urology, 5, 254-264. doi:10.1016/j.jpurol.2009.02.199
[3]	Paduch, D.A. (2007) Viral lower urinary tract infections. Current Urology Reports, 8, 324-335. doi:10.1007/s11934-007-0080-y
[4]	Dropulic, L.K. and Jones, R.J. (2008) Polyomavirus BK infection in blood and marrow transplant recipients. Bone Marrow Transplantation, 4, 11-18. doi:10.1038/sj.bmt.1705886
[5]	Leung, A.Y., Chan, M.T., Yuen, K.Y., et al. (2005) Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation. Clinical Infectious Diseases, 40, 528-537. doi:10.1086/427291
[6]	Hughes, A.J., Schwarer, A.P. and Millar, I.L. (1998) Hyperbaric oxygen in the treatment of refractory hemorrhagic cystitis. Bone Marrow Transplant, 22, 585-586. doi:10.1038/sj.bmt.1701376
[7]	Droller, M.J., Saral, R. and Santos, G. (1982) Prevention of cyclophosphamide-induced hemorrhagic cystitis. Urology, 20, 256-258. doi:10.1016/0090-4295(82)90633-1
[8]	Saad, E.R., Bresnahan, B.A., Cohen, E.P., et al. (2008) Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy. Transplantation, 85, 850-854. doi:10.1097/TP.0b013e318166cba8
[9]	Vats, A., Shapiro, R., Singh Randhawa, P., et al. (2003) Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults. Transplantation, 75, 105-112. doi:10.1097/00007890-200301150-00020
[10]	Sener, A., House, A.A., Jevnikar, A.M., et al. (2006) Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: One-year follow-up of renal allograft recipients. Transplantation, 81, 117-120. doi:10.1097/01.tp.0000181096.14257.c2